Navigation Links
Poll of Infection Prevention and Control Professionals Reveals MRSA Prevention Progress Six Months After National Survey
Date:12/10/2007

IPCPs Adopting Stronger Interventions but Say Facilities Must Do More

WASHINGTON, Dec. 11 /PRNewswire-USNewswire/ -- A poll of infection prevention professionals conducted six months after the Association for Professionals in Infection Control and Epidemiology's (APIC's) national MRSA Prevalence Study indicated that while 59 percent of the 2,100 who responded are adopting or have already adopted interventions to address Methicillin-resistant Staphylococcus aureus (MRSA), 50 percent said their health care facility is not doing as much as it could or should to stop the transmission of MRSA.

MRSA is a virulent multi-drug resistant organism. Interventions adopted ranged from increased hand hygiene compliance and testing of high-risk groups to the more comprehensive approach outlined in APIC's Guide to the Elimination of MRSA Transmission in Hospital Settings.

"We took this informal poll of our membership to get a sense of the pace of progress and what's changed in the six months since our MRSA Prevalence Study," said Kathy L. Warye, Chief Executive Officer of APIC. "We are encouraged that many hospitals are empowering infection prevention professionals to implement more MRSA prevention measures. However, it's concerning that many infection prevention programs are still inadequately funded and that facilities lack resources, staff and buy-in from senior management to prevent the transmission of MRSA."

Two recent studies have brought increased attention to MRSA. In June, APIC released the first national MRSA Prevalence Study which is being published in the December issue of the American Journal of Infection Control. This was followed by a CDC report published in the Journal of the American Medical Association in October.

"Our members understand the severity of this issue and are aggressively addressing MRSA, but the scope of this public health threat demands commitment and participation from every hospital, at all levels of the facility," said Denise Murphy, president of APIC and Vice President of Safety and Quality, and Chief Patient Safety and Quality Officer at Barnes-Jewish Hospital at Washington University Medical Center in St. Louis. "Hospitals should commit the resources to conduct a thorough risk assessment of patient populations and implement viable strategies to prevent MRSA and other antimicrobial-resistant infections."

APIC guidelines for the elimination of MRSA transmission include a risk assessment to identify high-risk areas for MRSA within the hospital; surveillance program to outline activities and procedures to identify MRSA cases; adherence to CDC hand hygiene guidelines; use of contact precautions (e.g., gloves, gowns and separating MRSA patients from other patients); environmental and equipment cleaning and decontamination, especially items that are close to patients such as bedrails and bedside equipment, and targeted active surveillance cultures (testing of high-risk groups).

"What health care leaders need to understand is that these interventions represent pennies on the dollar compared to the costs of infections once they occur. Reducing these infections saves both lives and scarce resources," said Warye. "APIC will conduct a thorough, formal study with our members in six months, and at that time we expect to see many more facilities in compliance with national guidelines."

Published in the December 2007 issue of the American Journal of Infection Control, the APIC MRSA Prevalence Study offers the most comprehensive understanding of MRSA to date. The study revealed that MRSA is significantly more widespread throughout health care facilities and across every state.

Findings demonstrate MRSA prevalence rates to be 46 in 1,000 patients, eight times higher than previous estimates. Of those, approximately 34/1,000 were infected while 12/1,000 patients were colonized. The APIC study was the first study to measure rates of both MRSA infection and colonization (patients carrying and able to transmit MRSA), to more accurately determine MRSA prevalence.

For more details on the study, including a full copy of the AJIC article, polling questions and results, and sample unedited comments from ICPs polled, please visit http://www.apic.org/Content/NavigationMenu/ResearchFoundation/NationalMRSAP revalenceStudy/MRSA_Study_Results.htm.

APIC's mission is to improve health and patient safety by reducing risks of infection and other adverse outcomes. The Association's more than 11,000 members have primary responsibility for infection prevention, control and hospital epidemiology in health care settings around the globe. APIC advances its mission through education, research, collaboration, practice guidance, public policy, and credentialing. Visit APIC online at http://www.apic.org


'/>"/>
SOURCE Association for Professionals in Infection Control andEpidemiology
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
2. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
3. Computers help chemists fight emerging infections
4. Infection contributes to the high rates of oropharyngeal cancers
5. Jefferson immunology researchers halt lethal rabies infection in brain
6. SIV infection of natural hosts provides new insights into HIV disease complexity
7. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
8. Natural aorta grafts have few side effects for infection-prone patients
9. Common misdiagnosis: most women believe they have a yeast infection when they dont
10. Patient Safety Authority Board of Directors Names Infection Advisory Panel
11. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... Program will serve more than ... the U.S. Soccer Foundation announced today that they have awarded nine grants to ... the Foundation’s soccer mentoring program, teaches kids the fundamentals of soccer while striving ...
(Date:2/17/2017)... ... 17, 2017 , ... Cancer diagnostics workflow solution provider Inspirata, ... – 22 in San Francisco. As part of the Tri-Conference expo, which is ... solution, as well as its new precision medicine platform, “Crosswalk Insight: Oncology™.” , ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... planning assistance to families and business owners in the greater Fort Lauderdale metropolitan ... organization. , For more than 30 years, LifeNet 4 Families has provided ...
(Date:2/16/2017)... Birmingham, AL (PRWEB) , ... February 17, 2017 ... ... asset protection assistance and financial planning services to families and entrepreneurs in the ... Bonnie, a local adoptive mother who needs assistance with her medically challenged son, ...
(Date:2/16/2017)... Angeles, CA (PRWEB) , ... February 16, 2017 , ... ... be confusing to the average patient. Parsa Mohebi, founder of Parsa Mohebi Hair Restoration, ... educate the public about the field of hair restoration, he recently expanded the information ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... --  Risperdal lawsuits involving gynecomastia (male breast growth) ... the atypical antipsychotic medication continue to move forward in ... Pleas, where the state,s Risperdal docket has been centralized ... posted on the Court,s website , the litigation ... 2017 at 11:00 a.m. (In Re: Risperdal Litigation, Case ...
(Date:2/17/2017)... Feb. 17, 2017  Featuring new ... at the  2017 HIMSS Conference & Exhibition (HIMSS17 ),  ... a global leader in health ... of population health management, acute healthcare ... integrated in a highly secure, cloud-based ...
(Date:2/17/2017)... YORK , Feb. 17, 2017  Noble Capital ... on ESSA Pharma Inc. (Nasdaq: EPIX ). ... Research, Kumar Raja , PhD. ESSA ... for castration resistant prostate cancer (CRPC). Its lead compound ... blocks the amino-terminal domain of the androgen receptor, thereby ...
Breaking Medicine Technology: